Cargando…
Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study
BACKGROUND: Refractoriness to platelet transfusion is an understudied phenomenon in critically ill patients. Our objective was to evaluate the prevalence, risk factors, and clinical outcomes of platelet refractoriness among patients in a tertiary-care intensive care unit (ICU). METHODS: A retrospect...
Autores principales: | Arabi, Saeed, Almahayni, Abdullah O., Alomair, Abdulrahman A., Masuadi, Emad M., Damlaj, Moussab, Al-Dorzi, Hasan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486553/ https://www.ncbi.nlm.nih.gov/pubmed/34603795 http://dx.doi.org/10.1155/2021/5589768 |
Ejemplares similares
-
Relapsed Angioimmunoblastic T Cell Lymphoma with Fulminant Leukemic Involvement
por: Altahan, Rahaf, et al.
Publicado: (2022) -
Critically ill patients with Middle East respiratory syndrome coronavirus infection
por: Al-Dorzi, Hasan M., et al.
Publicado: (2016) -
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
por: Abuelgasim, Khadega A., et al.
Publicado: (2019) -
Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014) -
Venous Thromboembolism in Critically Ill Cirrhotic Patients: Practices of Prophylaxis and Incidence
por: Al-Dorzi, Hasan M., et al.
Publicado: (2013)